These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 20430150

  • 1. Comparison of postoperative morphine requirements in healthy living liver donors, patients with hepatocellular carcinoma undergoing partial hepatectomy, and liver transplant recipients.
    Chen JP, Jawan B, Chen CL, Wang CH, Cheng KW, Wang CC, Concejero AM, Villagomeza E, Huang CJ.
    Transplant Proc; 2010 Apr; 42(3):701-2. PubMed ID: 20430150
    [Abstract] [Full Text] [Related]

  • 2. Pain management of living liver donors with morphine with or without ketorolac.
    Kao CW, Wu SC, Lin KC, Chen CL, Huang CJ, Cheng KW, Jawan B, Wang CH.
    Transplant Proc; 2012 Mar; 44(2):360-2. PubMed ID: 22410016
    [Abstract] [Full Text] [Related]

  • 3. Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors.
    Ko JS, Choi SJ, Gwak MS, Kim GS, Ahn HJ, Kim JA, Hahm TS, Cho HS, Kim KM, Joh JW.
    Liver Transpl; 2009 Apr; 15(4):381-9. PubMed ID: 19326422
    [Abstract] [Full Text] [Related]

  • 4. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD.
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [Abstract] [Full Text] [Related]

  • 5. Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation.
    Wang CH, Chen CL, Cheng KW, Huang CJ, Chen KH, Wang CC, Concejero AM, Cheng YF, Huang TL, Chiu KW, Wang SH, Lin CC, Liu YW, Jawan B.
    Transplant Proc; 2008 Oct; 40(8):2489-91. PubMed ID: 18929775
    [Abstract] [Full Text] [Related]

  • 6. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, Yagci RV, Aydogdu S.
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [Abstract] [Full Text] [Related]

  • 8. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 9. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD.
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [Abstract] [Full Text] [Related]

  • 10. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S, Sydoruk T, White I, Ekstein MP, Marouani N, Chazan S, Skornick Y, Weinbroum AA.
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 12. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
    Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ, Ha TY, Song GW.
    Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
    [Abstract] [Full Text] [Related]

  • 13. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
    Southworth S, Peters J, Rock A, Pavliv L.
    Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
    [Abstract] [Full Text] [Related]

  • 14. [Postoperative pain trajectories to identify risk of chronic postsurgical pain in living donors for liver transplantation].
    Bonnet A, Lavand'homme P, France MN, Reding R, De Kock M.
    Ann Fr Anesth Reanim; 2012 Dec; 31(12):945-9. PubMed ID: 23117039
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults.
    Van Vlierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B.
    Transplantation; 2004 Jan 27; 77(2):210-4. PubMed ID: 14742983
    [Abstract] [Full Text] [Related]

  • 16. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD.
    Arch Surg; 2009 Jan 27; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [Abstract] [Full Text] [Related]

  • 17. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N, Khalaf H, Fagih M, Al-Sebayel M.
    Exp Clin Transplant; 2008 Mar 27; 6(1):14-24. PubMed ID: 18405240
    [Abstract] [Full Text] [Related]

  • 18. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 27; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 19. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
    Humar A, Beissel J, Crotteau S, Kandaswamy R, Lake J, Payne W.
    Transplantation; 2008 May 27; 85(10):1420-4. PubMed ID: 18497681
    [Abstract] [Full Text] [Related]

  • 20. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y, Ichida T, Watanabe H, Yamamoto S, Abo T, Hatakeyama K.
    Hepatogastroenterology; 2003 May 27; 50(54):2161-5. PubMed ID: 14696487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.